Drug Type Nanobody |
Synonyms HP 1901, HP1901 |
Target |
Mechanism IL-17A inhibitors(Interleukin 17A inhibitors), IL-17F inhibitors(Interleukin-17F inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Preclinical | CN | 21 Jun 2019 | |
Psoriasis | Preclinical | CN | 21 Jun 2019 |